AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beron, P. J.
Right arrow Articles by Vicini, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beron, P. J.
Right arrow Articles by Vicini, F. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 167, 1409-1414, Copyright © 1996 by American Roentgen Ray Society


ARTICLES

Pathologic and mammographic findings predicting the adequacy of tumor excision before breast-conserving therapy

PJ Beron, EM Horwitz, AA Martinez, KJ Wimbish, AJ Levine, G Gustafson, PY Chen, JA Ingold and FA Vicini
Western Tumor Medical Group, Sepulveda, Sherman Oaks, CA 91411, USA.

OBJECTIVE: We performed a retrospective review to determine the need for reexcision after excisional biopsy in patients with breast cancer who were treated with breast-conserving therapy. MATERIALS AND METHODS: Eighty-seven patients with infiltrating ductal carcinoma of the breast underwent excisional biopsy followed by reexcision of the tumor site. Reexcision specimens were evaluated for residual disease and correlated with initial mammographic and pathologic findings. RESULTS: Tumors with an extensive intraductal component (EIC) were more likely to have residual disease at reexcision than those without an EIC (65% versus 6%, p < .01). Initially positive margins did not predict residual disease at reexcision significantly better than did initially negative margins (29% versus 13%, p = .08). Suspicious mammographic calcifications, absence of a discernible mass detected mammographically, or both were associated with a significantly increased risk of residual disease at reexcision. By combining all features (EIC, margin status, and mammography), we found that subsets of patients had significantly different risks of residual disease, which ranged from 6% to 83% (p < .01). CONCLUSION: Mammographic and pathologic findings are useful in predicting the adequacy of breast resection before radiation therapy in patients treated with breast- conserving therapy. An EIC is the most useful predictor of residual disease at reexcision. When combined, EIC, margin status, and mammographic findings form a powerful tool to judge the need for reexcision before radiation therapy.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
M. F. Dillon, A. D. K. Hill, C. M. Quinn, E. W. McDermott, and N. O'Higgins
A Pathologic Assessment of Adequate Margin Status in Breast-Conserving Therapy
Ann. Surg. Oncol., March 1, 2006; 13(3): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. A. Frei, K. Kinkel, H. M. Bonel, Y. Lu, L. J. Esserman, and N. M. Hylton
MR Imaging of the Breast in Patients with Positive Margins After Lumpectomy: Influence of the Time Interval Between Lumpectomy and MR Imaging
Am. J. Roentgenol., December 1, 2000; 175(6): 1577 - 1584.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Liljegren, L. Holmberg, J. Bergh, A. Lindgren, L. Tabar, H. Nordgren, and H.O. Adami
10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial
J. Clin. Oncol., August 1, 1999; 17(8): 2326 - 2326.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Roentgen Ray Society.